NanoView Biosciences, Inc. — Form D
NanoView Biosciences, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-01. The offering totals $5.0M, of which $2.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-03-01
- Form: D
- Accession: 0001754605-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $2.5M
- Remaining: $2.5M
- Investors: 2
- Date of first sale: 2022-02-15
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-435377
Issuer
- Name: NanoView Biosciences, Inc.
- CIK: 0001754605
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 1380 SOLDIERS FIELD ROAD, BOSTON, MA, 02135
- Phone: 339-499-8268
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Parker Cassidy | Director | SANTA CLARA, CA |
| GEORGE DAABOUL | Director | Waltham, MA |
| Andrea Jackson | Director | Marlborough, MA |
| GERALD WILLIAMSON | Director | BOSTON, MA |
| DAVID FREEDMAN | Executive Officer | Waltham, MA |
| GERALD WILLIAMSON | Executive Officer | BOSTON, MA |
| IAN RATCLIFFE | Director | Cambridge, MA |
| Michael Rubin | Director | Richmond Hill, A6 |
| GEORGE DAABOUL | Executive Officer | Waltham, MA |
Other filings by this issuer (2)
More